Table 2. Features of the research population with median values and percentages.
| Variables | N | Median (range) | n (%) |
|---|---|---|---|
| Patient characteristics | |||
| Age (years) | 164 | 71 (31–92) | — |
| Diabetes | 164 | — | 19 (11.6) |
| Peripheral vascular disease | 164 | — | 8 (4.9) |
| BMI (kg m–2) | 155 | 26.6 (17.6–48.4) | — |
| Continuation of antibiotics | 162 | — | 99 (61.1) |
| Surgical technique | |||
| Bilateral IFL | 164 | — | 137 (83.5) |
| En bloc | 164 | — | 73 (44.5) |
| Ligation saphenous vein | 160 | — | 32 (20.0) |
| Total nodes dissected (no. of nodes) | 164 | 9 (0–25) | — |
| Total positive nodes (no. of nodes) | 164 | 0 (0–7) | — |
| Extracapsular growth (no. of nodes) | 164 | 0 (0–7) | — |
| Postoperative management | |||
| Duration drain (days) | 149 | 8 (0–27) | — |
| Drain production last day (ml) | 122 | 40.0 (0–860) | — |
| Total drain production (ml) | 145 | 630 (20–7540) | — |
| Adjuvant radiotherapy | 163 | — | 40 (24.5) |
| Hospital stay (days) | 164 | 15 (4–60) | — |
| Follow-up (months) | 164 | 50.3 (0.1–215) | — |
| FIGO stage (new) | 164 | — | |
| IB | 78 (47.6) | ||
| II | 8 (4.9) | ||
| IIIA | 24 (14.6) | ||
| IIIB | 11 (6.7) | ||
| IIIC | 29 (17.7) | ||
| IIIA/B | 9 (5.5) | ||
| IVA | 4 (2.4) | ||
| IVB | 1 (0.6) | ||
Abbreviations: BMI=body mass index; FIGO=International Federation of Gynaecology and Obstetrics; N=number of patients with valid observation; n=number of patients with specific feature; IFL=inguinofemoral lymphadenectomy; —=not applicable.